TAMARA YOUNG: Open Payments
NPI 1558722983 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$828 in 36 payments from 12 companies in 2025. Trend: 2023 $345 · 2024 $509 · 2025 $828
Food & beverage: $763Education: $66
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $228 |
| Regeneron Healthcare Solutions, Inc. | 8 | $163 |
| Novartis Pharmaceuticals Corporation | 4 | $104 |
| Genentech USA, Inc. | 3 | $62 |
| GENZYME CORPORATION | 2 | $56 |
| Amgen Inc. | 2 | $56 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $51 |
| Organon LLC | 1 | $26 |
| CSL Behring | 1 | $22 |
| PFIZER INC. | 1 | $21 |
Products named: DUPIXENT, TEZSPIRE, FASENRA, Xolair, NEFFY, BREZTRI, AYVAKIT, Rhapsido.
Industry payments across CO — which companies pay providers there.
